Skye Bioscience

Skye and Redx combine with $125M to advance fibrosis assets

Skye Bioscience and Redx Pharma have combined in a deal that will net $125 million in financing for the new public company, called Fibrx Therapeutics.

Will Maddox Aug 14, 2026 2:05pm